Monthly Archives: November 2016

Highlights from APHA: a Q&A with Professor Guohua Li

apha-logo

Professor Guohua Li

Earlier this month the American Public Health Association (APHA) annual meeting took place in Denver. The event brought more than 12,000 health professionals together, from across the U.S and the rest of world, to discuss issues related to this year’s theme ‘Creating the Healthiest Nation: Ensuring the Right to Health’. Attending the event was Journal Development Editor Helen Metherell and Editor-in-Chief of the Springer Open journal Injury Epidemiology Professor Guohua Li. Here Helen interviews him on his role at the conference and his personal highlights. This blog was originally posted by Springer Open, a sister company of Biomed Central.

Health

‘Tis the season to get tested

heptestweek

Jeffrey V. Lazarus

Who has hepatitis? Well, that’s a good question. We know that some groups are more likely to acquire HCV infection than others. But, unfortunately, most people who have the virus have not yet been diagnosed. November 2016 marks the fourth European Testing Week – and the second to include hepatitis. It is now well known… Read more »

Health

Managing the hypertension pandemic in China: a call for system thinking

pressure

Kehui Huang

Non-communicable diseases (NCDs) are threatening global sustainable development. The hypertension pandemic has gained a lot of concern in China recently for both policy makers and analysts. In spite of the severity, international evidence has illustrated that hypertension could be well managed with low-tech, cost-effective and feasible interventions that are delivered from qualified primary care, even in low resource settings.

Health

An interview with Emilis Subata on the European Joint Action’s work on sustainable & long-term funding for HIV, TB and HCV

emilissubata

Jeffrey V. Lazarus

The Joint Action on HIV and Co-Infection Prevention and Harm Reduction (HA-REACT) addresses knowledge gaps in the prevention of HIV and co-infections including tuberculosis (TB) and viral hepatitis among people who inject drugs (PWID). The project is primarily funded by the European Union and implemented by 23 partners in 18 member states. There are also 14 additional collaborating partners including the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

Health

An interview with Luis Sordo del Castillo on the European Joint Action’s work on harm reduction

hareactprofile

Jeffrey V. Lazarus

The Joint Action on HIV and Co-Infection Prevention and Harm Reduction (HA-REACT) addresses knowledge gaps in the prevention of HIV and co-infections including tuberculosis (TB) and viral hepatitis among people who inject drugs (PWID). The project is primarily funded by the European Union and implemented by 23 partners in 18 member states. There are also 14 additional collaborating partners including the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

Health